Alembic Pharma shares hit 20% upper circuit after strong Q2 resultsShares of Alembic Pharmaceuticals rallied to hit 20 percent upper circuit on Wednesday, November 4, after the company reported strong performance in the July-September quarter of the financial year (Q2 FY27), with robust growth in profitability and revenue.

Alembic Pharmaceuticals’ shares opened at Rs 809.90 and surged 20 percent to hit the upper circuit of Rs 965. The stock closed at Rs 804.20 on previous day, on the BSE.

The stock later pared some gains and at around 3.10 pm, was trading 13.49 percent higher at Rs 912.65 a piece.

Alembic Pharmaceuticals’ net profit surged 81.1 percent to Rs 335 crore in second quarter of FY27 from Rs 185 crore in the year-ago period.

The pharmaceutical company reported a 36.3 percent year-on-year increase in revenue to Rs 2,603 crore in Q2 FY27, compared Rs 1,910 crore in the corresponding quarter of the last financial year.

The company’s EBITDA jumped 78.7 percent to Rs 563 crore from Rs 315 crore. EBITDA margin improved sharply to 21.6 percent in Q2 FY27 from 16.5 percent in corresponding quarter of last fiscal.